Health Care

health marketplace

For four decades, health care clients have trusted Ropes & Gray to craft innovative solutions and provide sophisticated and strategic advice on transactions, regulatory issues and government investigations. 

Contact

“This highly regarded firm is considered a significant force due to its broad regulatory expertise which includes advising clients on litigation, transactional and policy matters. Its deep FDA capabilities informed significant First Amendment litigation regarding off-label promotions, and its health care group has worked extensively on matters involving the impact of the Affordable Care Act.” Chambers USA
“They have been exceptional - they have provided a broad base of knowledge and expertise.” Health Care Client, Chambers USA
“The firm’s healthcare team has established a reputation for producing consistently high-quality work.” Chambers USA

Overview

The health care industry in the 21st century faces tremendous change driven by growing demand, new technologies, shifting business models and intense government scrutiny. Clients benefit from Ropes & Gray’s deep experience in health care law, and our intimate knowledge of our clients’ industries, which position the firm to preempt and resolve legal issues across the full range of relevant practices.

More than 60 attorneys in Ropes & Gray offices across the United States represent virtually every sector of the global health care industry, including academic medical centers and community hospitals, health care investors and financial institutions, medical schools, pharmaceutical companies, pharmacy benefit managers, medical device companies, managed care organizations and insurance companies, health care provider organizations, physician practice groups, health care technology companies, biomedical companies, and long-term care and nursing home providers.

Our geographic scope covers major industry hubs throughout the U.S. and in international markets, with U.S. offices in Boston, New York, Washington, D.C., Chicago and San Francisco, and offices, or structured networks, in pivotal global territories including London, India, Korea, China and Japan. Our experience in, and knowledge of, the health care community positions our attorneys to analyze complicated regulatory issues, anticipate trends and new initiatives, and develop creative, strategic and felicitous business solutions.

The success of our health care practice has been recognized by leading independent observers. In 2019, we were honored as “Practice Group of the Year” by Law360, making Ropes & Gray the only firm to be recognized in both the health care and private equity categories. The Financial Times Innovative Lawyers 2019 also honored the firm’s cutting-edge work in the health care sector. Our health care practice is consistently ranked highly by Chambers USA, which named Ropes & Gray “Firm of the Year” for health care in 2015. U.S. News–Best Lawyers “Best Law Firms” 2019 named Ropes & Gray a top-tier firm in the U.S. for “Health Care Law.” And The Legal 500 US 2019 recognized Ropes & Gray for “Healthcare: Service Providers,” with multiple attorneys listed as leaders in the field.  

Services

Ropes & Gray’s health care group provides a comprehensive range of services, including: 

Strategic Counseling

Ropes & Gray has a long history of advising health care clients on matters of corporate governance, organizational structure and strategic direction. Our work in this area includes structuring governing body and governance relationships – of either a corporate or a contractual nature – that function as required.

We have extensive experience advising clients on: 

  • Governance and fiduciary standards 
  • Managed care contracting 
  • System network and design 
  • Public policy initiatives 
  • Government relations 
  • Strategic positioning 
  • Organizational structure 
  • Physician integration 
  • Accountable Care Organizations developments

Transactional & Capital Finance

Ropes & Gray has deep experience representing clients from virtually every sector of the global health care industry on a broad array of transactions. We regularly advise clients on:

  • Mergers and acquisitions
  • Disaffiliations and separations 
  • Joint ventures and partnerships 
  • Affiliations, research collaborations and licensing agreements 
  • Revenue development 
  • Complex commercial agreements 
  • Tax-exempt bond financing

Regulatory

Compliance with state and federal regulation has proven an increasingly prominent concern among managers of health care institutions, both in the context of day-to-day operations and in connection with individual strategic transactions. At Ropes & Gray, we apply our experience in regulatory matters to help  clients successfully align their institutional practices with the directives outlined by regulatory bodies. In more than 15 states we have advised our clients on regulatory issues related to transactions and have leveraged our knowledge of the regulation of risk-based insurance contracts. 

Our vast experience on regulatory issues covers:

  • Medicare, Medicaid and third-party reimbursement 
  • Federal health care regulatory issues (e.g., FDA, Stark, HIPAA, IRB) 
  • Clinical research 
  • Fraud and abuse 
  • Health privacy and security 
  • Antitrust 
  • Licensure 
  • Public health oversight 
  • Intermediate sanctions 
  • Government enforcement

Clients

We represent participants in virtually every sector of the health care industry, including:

  • Academic medical centers 
  • Ambulatory care centers 
  • Ancillary services providers 
  • Biotechnology companies 
  • Cancer centers 
  • Catholic hospitals and health systems 
  • Children’s hospitals 
  • Clinical laboratories 
  • Contract research organizations 
  • Disease management companies 
  • Health care lenders, investors and underwriters 
  • Health maintenance organizations and other managed care entities 
  • Health plans and other health insurers 
  • Home health providers 
  • Hospitals and health systems 
  • Insurance companies 
  • Integrated delivery systems 
  • Managed and integrated care providers 
  • Investment banks 
  • Medical schools and teaching hospitals 
  • Medical device, equipment and information technology companies 
  • Nursing homes, skilled nursing facilities and assisted living facilities 
  • Pharmacy benefit managers 
  • Pharmaceutical companies 
  • Physician practice groups/management companies 
  • Post-acute and long-term providers 
  • Private equity firms 
  • Research institutions 
  • Specialty hospitals

Insights

See all events

Award for Excellence

COVID-19 RESOURCES

Coronavirus Landing Site

Value-Based Health Care

Ropes & Gray's health care group has launched an online hub for articles, webinars, research materials and other valuable resources dedicated to value-based health care, all organized by industry segments and topics:

» Visit the value-based health care website

Ropes & Gray Represents uniQure in $1.6 Billion Global Licensing Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy

Ropes & Gray represented Amsterdam-based gene therapy company uniQure N.V. in a licensing agreement to provide biopharmaceutical company CSL Behring with exclusive global rights to uniQure’s investigational gene therapy for patients with hemophilia B. The transaction ...

View all

Stephen Warnke Named a Finalist for The New York Law Journal’s “Attorney of the Year” Award

A long-time New York City healthcare lawyer, and partner in the firm’s health care practice, Stephen Warnke has been named one of three finalists for The New York Law Journal’s prestigious “Attorney of the ...

View all

FDA Regulatory Chair Presents at Food and Drug Law Institute’s Webinar on FDA’s Recent COVID-19 Guidances

FDA regulatory partner and practice chair Greg Levine (Washington, D.C.) presented at the Food and Drug Law Institute’s webinar on April 14 titled “FDA’s Recent COVID-19 Guidances Facilitating Expanded Access to Certain Medical ...

View all

Cookie Settings